Revolutionizing Breast Cancer Detection: Breast Tissue Markers Market Size to US$ 6.5 Billion by 2033, Persistence Market Research

Breast Tissue Markers Market Segmented By Coil, Butterfly, Wing, Ribbon, Barrel, Bowtie, Triple Twist, U-shape, Barbell Tribell, Anchor Product with Material such as Titanium, Nitinol, Stainless steel, Hydrogel, Collagen, Natural mineral, Zirconium-Oxide

New York, July 26, 2023 (GLOBE NEWSWIRE) -- The global market for breast tissue markers recorded a valuation of US$ 2.7 billion in 2022 and is forecasted to expand at a CAGR of 8.4% from 2023 to 2033. Increasing incidence of breast cancer has necessitated accurate identification of tumor markers for treatment development and clinical management.

Breast lesions require further diagnostic workup, including biopsy and pathology diagnosis. Clinical biomarkers are crucial in diagnosing and treating breast cancer, with three molecular biomarkers being estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).

Supercharge Your Business Strategy with Market Intelligence: Request Your Free Sample Copy now@ https://www.persistencemarketresearch.com/samples/29812

These biomarkers provide prognostic information and predict therapy response. Biomarker status is established through the histological examination of immunohistochemistry (IHC) stained tissue, and biomarker profiles are linked to histologic characteristics.

According to a research article published in PLOS in 2016, breast tumors are categorized based on their origin, with ductal tumors accounting for approximately 80% and lobular tumors constituting 10% to 15% of all breast cancer cases.

The 2019 American Society of Clinical Oncology and College of American Pathologists guidelines recommend follow-up if discrepancies occur between the ER (estrogen receptor) status and histologic findings. A repeat IHC staining or a second review is necessary to rule out technical difficulties, interpretation variability, or tumor heterogeneity before using biomarker status for treatment decisions.

With government push for early diagnosis, technological advances for marker identification, and improved healthcare facilities, breast cancer can be controlled.

As reported by the World Cancer Research Fund International in 2020, breast cancer is the most commonly occurring cancer worldwide, contributing to nearly 11% of the global cancer burden. The number of new cases of breast cancer in women reached approximately 2.26 million in 2020.

If you want to Purchase Specific Insights By Segment/Region/Competitor, Request For Customization@ https://www.persistencemarketresearch.com/request-customization/29812

Key Takeaways from Market Study

The global breast tissue markers market is anticipated to reach US$ 6.5 billion by the end of 2033.

By product, sales of metal breast tissue markers reached US$ 2 billion in 2022.

By shape, sales of coil-shaped markers accounted for US$ 967.5 million in 2022.

By material, biodegradable breast tissue markers reached sales of US$ 1.8 billion in 2022.

By end user, hospitals led with 59% market share in 2022.

North America led the global market with the United States contributing US$ 863.5 million in 2022.

“Extensive utilization of biodegradable breast tissue markers with coils for cancer diagnosis in emerging and industrialized nations is contributing significantly to market growth,” says an analyst at Persistence Market Research.

Market Competition

Manufacturers are tackling competition and rising demand for breast tissue marker therapies by acquiring other established manufacturers and investing in research and development through collaborations for novel, cost-effective solutions.

Major Key Players are: Alleima, BD, Varay Laborix, Hologic, Inc., Mammotome, Varay Laborix, Argon Medical Devices, Mermaid Medical A/S, Medtronic, Carbon Medical Technologies, Inc., Scion Medical Technologies, LLC, SOMATEX Medical Technologies GmbH

Recent Developments

In January 2021, Hologic acquired SOMATEX Medical Technologies for US $64 million. SOMATEX, a developer of biopsy site markers and localization technologies, supports Hologic's breast health solutions and is expected to help Hologic expand its sales presence in Europe.

In February 2020, Endomag introduced the Magseed® magnetic marker for accurate cancer site removal in soft tissue, ensuring precise staging for breast cancer patients in Europe.

If You Want To Know the Business Opportunity/Market Value, Purchase The Premium Insight @ https://www.persistencemarketresearch.com/checkout/29812

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the breast tissue markers market in its latest study, presenting a historical demand assessment for 2017 to 2022 and projections for 2023 to 2033.

The research study is based on product (metal [titanium breast tissue markers, stainless steel breast tissue markers, nickel breast tissue markers], non-metal [ceramic breast tissue markers, zirconium oxide breast tissue markers]), shape (coil, ribbon, butterfly, V-shape, others), material (biodegradable, non-biodegradable), and end user (hospitals, ambulatory surgical centers, cancer research centers, diagnostic centers), across seven key regions of the world.

For additional insights on how the growth of the breast tissue markers market will unfold over the decade, write to the analyst at [email protected]

Other Trending Reports:

Meningococcal Vaccines Market

Dry Eye Syndrome Treatment Market Share

Wearable Injectors Market Type

Ventricular Assist Devices

Dental Adhesives Market Size

Bariatric Surgery Devices Market

Medical Electrodes Market

Biosimilar Insulin Market

Persistence Market Research’s Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.

ContactRajendra Singh Persistence Market Research U.S. Sales Office:305 Broadway, 7th FloorNew York City, NY 10007+1-646-568-7751United StatesUSA - Canada Toll-Free: 800-961-0353Email: [email protected]